Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,847 | -6,999 | -3,837 | -50,860 | -38,821 |
| Depreciation Amortization | 16 | 98 | 69 | 324 | 266 |
| Income taxes - deferred | N/A | -382 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 218 | -1,978 | 789 | 898 | 1,421 |
| Other Working Capital | 1,568 | -3,033 | 1,145 | 3,075 | 782 |
| Other Operating Activity | -103 | -5,782 | 264 | 5,866 | 4,163 |
| Operating Cash Flow | $-13,149 | $-18,074 | $-1,570 | $-40,697 | $-32,189 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 275 | N/A | -189 | -687 |
| Net Acquisitions | N/A | 29,107 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $29,382 | $N/A | $-189 | $-687 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 5,000 | 11,022 |
| Debt Repayment | N/A | N/A | -16 | N/A | -1,489 |
| Common Stock Issued | 29,827 | 750 | 1,513 | 17,554 | 315 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -764 |
| Financing Cash Flow | $29,827 | $750 | $1,497 | $22,554 | $9,085 |
| Beginning Cash Position | 12,162 | 104 | 176 | 106,399 | 130,189 |
| End Cash Position | 28,840 | 12,162 | 104 | 88,068 | 106,399 |
| Net Cash Flow | $16,678 | $12,058 | $-72 | $-18,331 | $-23,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,149 | -18,074 | -1,570 | -40,697 | -32,189 |
| Capital Expenditure | N/A | N/A | N/A | -189 | -687 |
| Free Cash Flow | -13,149 | -18,074 | -1,570 | -40,886 | -32,875 |